Hosted on MSN8mon
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
plus Herceptin (trastuzumab) for subcutaneous injection (SC) versus Perjeta plus Herceptin for SC and optional physician's choice of endocrine therapy as a maintenance treatment in HER2-positive ...
Cure Today10d
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...
Nature5y
Roche plans for more convenient-to-use Herceptin and Rituxan
Before that, the Swiss pharma owned part of the company and held marketing rights outside the US to Herceptin as well as other Genentech drugs. Typically, the volume of a subcutaneous injection is ...
pharmaphorum5y
As 'big three' oncology meds lose sales, Roche looks to file subcutaneous breast cancer combo
A subcutaneous formulation of Roche’s Perjeta and Herceptin breast cancer drugs ... “With this single injection under the skin, people with HER2-positive breast cancer receiving Perjeta ...
Nature4y
Enhanced hyaluronidase-based drug delivery
Biotechnology pioneer Halozyme has developed ENHANZE, a drug delivery technology that can enable and optimize the subcutaneous ... from hours to minutes. • Herceptin SC administration reduces ...